Ten-Year Counterdrug Technology Plan and Development
Roadmap
Message from the Director
Technology holds the promise for stemming the effects of drug abuse on our country. The
purpose of this document is to provide a Ten-Year Counterdrug Technology Plan and
Development Roadmap that organizes the federal government's advanced technology
development initiatives to support the five goals of the National Drug Control Strategy.
The plan was prepared by an interagency working group for technology (IAWG-T) composed
of representatives from Department of Defense, Drug Enforcement Administration, Federal
Bureau of Investigation, Immigration and Naturalization Service, National Institute on
Drug Abuse, National Institute of Justice, United States Coast Guard, United States
Customs Service, and Central Intelligence Agency. The Office of National Drug Control
Policy, Counterdrug Technology Assessment Center, coordinated the efforts of the IAWG-T in
preparing the technology plan and development roadmap.
The IAWG-T's task was to arrive at a development roadmap and program schedule in
support of a comprehensive ten-year counterdrug technology plan. The counterdrug
technology efforts addressed within the plan focus on improving the capabilities of law
enforcement agencies, including state and local organizations, charged with reducing the
availability of illegal drugs. The plan also outlines necessary advancements within the
demand reduction program for medical research and medical applications as well as the
education of young people concerning drug abuse.
The recently released Performance Measures of Effectiveness System provides the impact
targets, performance measures, and outcomes needed to evaluate our progress and overall
performance. This plan will be updated and revised annually in keeping with our
accomplishments and the changing needs of both supply and demand reduction. The plan
supports flexible regional scenarios, and it has already contributed to the selection of
advanced, non-intrusive inspection technologies proposed for deployment along the
Southwest border over the next five years.
Barry R. McCaffrey, Director
Office of National Drug Control Policy
